← Open Payments lookup

KABIRU AKERE: Open Payments

NPI 1043659444 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$644 in 21 payments from 9 companies in 2025. Trend: 2023 $301 · 2024 $226 · 2025 $644

Food & beverage: $644
CompanyPaymentsAmount
Novo Nordisk Inc6$219
Boehringer Ingelheim Pharmaceuticals, Inc.6$142
Corcept Therapeutics2$141
Soleno Therapeutics, Inc.1$30
Lilly USA, LLC2$30
Phadia US Inc.1$26
Dexcom, Inc.1$24
AstraZeneca Pharmaceuticals LP1$17
Amgen Inc.1$15

Products named: Ozempic, JARDIANCE, Korlym, VYKAT XR, ImmunoCAP, Dexcom G6 Transmitter, Rybelsus, Wegovy.

Industry payments across TX — which companies pay providers there.